Skip to main content
Livermore
Livermore
ZHEN

Intellectus Partners, LLC

SEC CIK
0001677253
Latest filing
Aug 12, 2026

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by Intellectus Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings

Shares (Q2 2026)
54,675
Value
$925.1K
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of NTLA by Intellectus Partners, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202654,675$925.1K0.2%+200+0.4%AddedHolders
Q1 202654,475$698.4K0.1%+3,350+6.6%AddedHolders
Q4 202551,125$459.6K0.1%−35,850−41.2%ReducedHolders
Q3 202586,975$1.50M0.3%+1,000+1.2%AddedHolders
Q2 202585,975$806.4K0.2%+3,150+3.8%AddedHolders
Q1 202582,825$588.9K0.1%+8,300+11.1%AddedHolders
Q4 202474,525$869.0K0.2%+15,700+26.7%AddedHolders
Q3 202458,825$1.21M0.3%+600+1.0%AddedHolders
Q2 202458,225$1.30M0.4%+1,225+2.1%AddedHolders
Q1 202457,000$1.57M0.4%+1,350+2.4%AddedHolders
Q4 202355,650$1.70M0.5%+4,900+9.7%AddedHolders
Q3 202350,750$1.60M0.5%−650−1.3%ReducedHolders
Q2 202351,400$2.10M0.6%+5,135+11.1%AddedHolders
Q1 202346,265$1.72M0.5%+600+1.3%AddedHolders
Q4 202245,665$1.59M0.6%+3,700+8.8%AddedHolders
Q3 202241,965$2.35M0.8%−1,260−2.9%ReducedHolders
Q2 202243,225$2.24M0.8%−1,225−2.8%ReducedHolders
Q1 202244,450$3.23M1.0%−3,075−6.5%ReducedHolders
Q4 202147,525$5.62M1.4%−3,425−6.7%ReducedHolders
Q3 202150,950$6.83M1.7%+2,300+4.7%AddedHolders
Q2 202148,650$7.88M1.8%−22,975−32.1%ReducedHolders
Q1 202171,625$4.61M1.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.